Decoy Therapeutics Builds Momentum with Accelerating Execution, Entering a Highly Catalytic Phase with a Clearly Defined Path to Clinical Development of its Antiviral Pipeline

"We are executing with urgency and purpose as we advance our pipeline assets to the clinic as expeditiously as possible," said Rick Pierce, Chief Executive Officer of Decoy Therapeutics. "We are ...
The Lancet

ChatGPT for obesity management: a review of evidence, potential challenges, and clinical implications

The global rise in the prevalence of obesity highlights the need for accessible and effective solutions for obesity management. ChatGPT, one of the fastest-growing artificial intelligence (AI) tools, ...